Jump to content

U.S. allows emergency use of first COVID-19 antibody drug


Recommended Posts

Posted

U.S. regulators on Monday authorized emergency use of the first experimental antibody drug for COVID-19 in patients who are not hospitalized but are at risk of serious illness because of their age or other conditions.

The drug is a monoclonal antibody โ€“ a widely used class of biotech drugs which in this case is a manufactured copy of an antibody the human body creates to fight infections.

A similar treatment developed by Regeneron Pharmaceuticals Inc was given to U.S. President Donald Trump after he caught the coronavirus in early October. The nationโ€™s top infectious disease expert Dr. Anthony Fauci said it likely contributed to Trumpโ€™s recovery.

Regeneron is also seeking an EUA for its dual-antibody against COVID-19.

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...